Bluejay Diagnostics (BJDX) Competitors $1.66 +0.04 (+2.16%) Closing price 03:35 PM EasternExtended Trading$1.64 -0.01 (-0.60%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. SSKN, NURO, CODX, SINT, POAI, LFWD, TNON, STRR, LUCY, and AMIXShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Strata Skin Sciences (SSKN), NeuroMetrix (NURO), Co-Diagnostics (CODX), Sintx Technologies (SINT), Predictive Oncology (POAI), Lifeward (LFWD), Tenon Medical (TNON), Star Equity (STRR), Innovative Eyewear (LUCY), and Autonomix Medical (AMIX). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Its Competitors Strata Skin Sciences NeuroMetrix Co-Diagnostics Sintx Technologies Predictive Oncology Lifeward Tenon Medical Star Equity Innovative Eyewear Autonomix Medical Strata Skin Sciences (NASDAQ:SSKN) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Do analysts rate SSKN or BJDX? Strata Skin Sciences presently has a consensus price target of $6.00, suggesting a potential upside of 152.10%. Given Strata Skin Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Strata Skin Sciences is more favorable than Bluejay Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Strata Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Bluejay Diagnostics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SSKN or BJDX more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -27.22%. Strata Skin Sciences' return on equity of -138.22% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Strata Skin Sciences-27.22% -138.22% -24.37% Bluejay Diagnostics N/A -322.46%-262.96% Which has more volatility and risk, SSKN or BJDX? Strata Skin Sciences has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Does the media refer more to SSKN or BJDX? In the previous week, Strata Skin Sciences and Strata Skin Sciences both had 1 articles in the media. Strata Skin Sciences' average media sentiment score of 0.00 equaled Bluejay Diagnostics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Strata Skin Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bluejay Diagnostics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders have more ownership in SSKN or BJDX? 32.4% of Strata Skin Sciences shares are held by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are held by institutional investors. 39.0% of Strata Skin Sciences shares are held by company insiders. Comparatively, 0.1% of Bluejay Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation and earnings, SSKN or BJDX? Bluejay Diagnostics has lower revenue, but higher earnings than Strata Skin Sciences. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStrata Skin Sciences$33.56M0.30-$10.09M-$2.27-1.05Bluejay Diagnostics$250K9.86-$7.72M-$379.740.00 SummaryStrata Skin Sciences beats Bluejay Diagnostics on 10 of the 14 factors compared between the two stocks. Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.42M$6.92B$5.54B$8.95BDividend YieldN/A1.23%5.38%4.08%P/E Ratio0.0026.6327.3820.03Price / Sales9.8699.70422.31120.16Price / CashN/A20.9736.6357.47Price / Book0.164.748.085.67Net Income-$7.72M$173.18M$3.16B$248.47M7 Day Performance6.09%1.52%2.12%2.90%1 Month Performance-7.02%0.14%4.43%5.75%1 Year Performance-94.75%28.37%35.62%21.36% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics0.1095 of 5 stars$1.66+2.2%N/A-95.0%$2.42M$250K0.009News CoverageSSKNStrata Skin Sciences2.8752 of 5 stars$2.29+1.8%$6.00+162.0%-14.6%$9.39M$33.56M-1.01120Gap DownNURONeuroMetrixN/A$4.55+4.4%N/A+26.4%$9.37M$3.03M-0.9920High Trading VolumeCODXCo-Diagnostics4.2089 of 5 stars$0.28+6.7%$5.50+1,862.9%-76.7%$8.81M$3.91M-0.24100Gap UpSINTSintx Technologies2.3909 of 5 stars$3.22flat$28.00+769.6%-26.0%$8.08M$2.89M-0.0640POAIPredictive Oncology2.166 of 5 stars$0.83+0.0%$3.00+261.4%-18.2%$7.41M$1.62M-0.2730News CoverageLFWDLifeward2.8325 of 5 stars$0.64-3.8%$9.00+1,295.8%-81.5%$7.38M$25.66M-0.2160Gap DownHigh Trading VolumeTNONTenon Medical1.4425 of 5 stars$0.98+2.9%$4.67+377.5%+38.4%$7.21M$3.28M-0.048STRRStar Equity3.593 of 5 stars$2.00-1.0%$5.00+150.0%-50.3%$6.48M$53.36M-0.58460Gap DownLUCYInnovative Eyewear0.5183 of 5 stars$2.12+1.9%N/A-78.6%$6.44M$1.64M-0.539AMIXAutonomix Medical3.2862 of 5 stars$1.57-21.9%$16.50+951.0%-91.9%$5.59MN/A-0.211Positive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies Strata Skin Sciences Alternatives NeuroMetrix Alternatives Co-Diagnostics Alternatives Sintx Technologies Alternatives Predictive Oncology Alternatives Lifeward Alternatives Tenon Medical Alternatives Star Equity Alternatives Innovative Eyewear Alternatives Autonomix Medical Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BJDX Stock Alerts